Publications

(Displaying in Reverse Chronological Order)

  1. Research
  2. Publications
  3. Publications
2566
Roy A and Chawla HPS. Biocatalysis in organic solvents: a process for multigram synthesis of 1,4:3,6-dianhydro-D-glucitol 2-acetate and its isomeric 5-acetate using immobilized lipase from Pseudomonas sp Enzyme and Microbial Technology 2001, 29, 490-493.
2567
Sharma R, Chisti Y and Banerjee UC. Production, purification, characterization, and applications of lipases Biotechnology Advances 2001, 19, 627-662.
2568
Shastri S, McNeill JR, Wilson TW, Ramarao P, Kaul CL and Gopalakrishnan V. Cysteinyl leukotrienes mediate enhanced vasoconstriction to angiotensin II but not endothelin-1 in SHR American Journal of Physiology: Heart and Circulatory Physiology 2001, 281, H342-H349..
2569
Singh B, Saxena AK, Chandan BK, Gupta DK, Bhutani KK and Anand KK. Adaptogenic activity of a novel withanolide fraction from the roots of Withania somnifera Dun Phytotherapy Research 2001, 15, 311-318.
2570
Singh DD, Dey CS and Bhutani KK. Down regulation of p34cdc2 by an aqueous fraction of Withania somnifera Phytomedicine 2001, 8, 492-494.
2571
Singh PP and Singh S. Protection of mice from malaria after co-administration of recombinant mouse granulocyte-macrophage colony- stimulating factor and methionine-enkephalin European Cytokine Network 2001, 12, 528-536.
2572
Singh S. Efforts of IUATLD/WHO to solve the problem of poor bioavailability of rifampicin from anti-tubercular FDC products: Is a change required in the direction of the approach in view of the recent findings International Journal of Tuberculosis and Lung Disease 2001, 5, 880-882.
2573
Singh S and Singh PP. Serum amyloid P-component-induced colony-stimulating factors production by macrophages Scandinavian Journal Of Immunology 2001, 53, 155-161.
2574
Tiwari P, Ramarao P, Ghosal S. Effects of Shilajit on the development of tolerance to morphine in mice Phytotherapy Research 2001, 15, 177-179.
2575
Venugopal K and Singh S. Evaluation of gelatins for cross-linking potential Pharmaceutical Technology 2001, .
2576
Bhushan B, Samanta SK, Chauhan A, Chakraborti AK and Jain RK. Chemotaxis and biodegradation of 3-methyl- 4-nitrophenol by ralstonia sp SJ98 Biochemical and Biophysical Research Communications 2000, 275, 129-133.
2577
Chauhan A, Chakraborti AK and Jain RK. Plasmid-encoded degradation of p-nitrophenol and 4-nitrocatechol by Arthrobacter protophormiae Biochemical and Biophysical Research Communications 2000, 270, 733-740.
2578
Gandhi R, Kaul CL and Panchagnula R. Validated LC method for in-vitro analysis of azithromycin using electrochemical detection Journal of Pharmaceutical and Biomedical Analysis 2000, 23, 1073-1079.
2579
Gandhi R, Sharma P, Chawla HPS, Kaul CL and Panchagnula R. HPLC analysis of tricyclic antidepressants in skin diffusion studies STP Pharma Sciences 2000, 10, 234-238.
2580
Grover M, Gulati M, Singh B and Singh S. Correlation of base hydrolysis rate constants of penicillins with structure Pharmacy and Pharmacology Communications 2000, 6, 355-363.
2581
Kanikkannan N, Singh J and Ramarao P. Transdermal iontophoretic delivery of timolol maleate in albino rabbits International Journal of Pharmaceutics 2000, 197, 69-76.
2582
Kaul CL and Ramarao P. Renin release and the sympathetic nervous system Drugs of Today 2000, 36, 699-713.
2583
Kaur J and Dey CS. Putative P-glycoprotein expression in arsenite-resistant Leishmania donovani down-regulated by verapamil Biochemical and Biophysical Research Communications 2000, 271, 615-619.
2584
Mariappan TT, Singh B and Singh S. A validated reversed-phase HPLC method for simultaneous determination of rifampicin, isoniazid and pyrazinamide in USP dissolution medium and simulated gastric fluid Pharmacy and Pharmacology Communications 2000, 6, 345-349.
2585
Panchagnula R, Agrawal S, Kaur KJ, Singh I and Kaul CL. Evaluation of rifampicin bioequivalence in fixed-dose combinations using the WHO/IUATLD recommended protocol International Journal of Tuberculosis and Lung Disease 2000, 4, 1169-1172.
2586
Panchagnula R, Kaur KJ, Singh I and Kaul CL. Bioequivalence of rifampicin when administered as a fixed-dose combined formulation of four drugs versus separate formulations Methods and Findings in Experimental and Clinical Pharmacology 2000, 22, 689-694.
2587
Pillai P, Nair VB, Borkute SD, Sivaprasad N and Panchagnula R. Indian Journal of Nuclear Medicine 2000, 15, 181-183.
2588
Prasad V and Dey CS. Tubulin is hyperphosphorylated on serine and tyrosine residues in arsenite-resistant Leishmania donovani promastigotes Parasitology Research 2000, 86, 876-880.
2589
Prasad V, Kaur J and Dey CS. Arsenite-resistant Leishmania donovani promastigotes express an enhanced membrane P-type adenosine triphosphatase activity that is sensitive to verapamil treatment Parasitology Research 2000, 86, 661-664.
2590
Prasad V, Kumar SS and Dey CS. Resistance to arsenite modulates levels of alpha-tubulin and sensitivity to paclitaxel in Leishmania donovani Parasitology Research 2000, 86, 838-842.
2591
Rajnikant, Goswami K, Gupta V, Bhutani KK and Magotra D. Crystallography of disogenin-3-6-dione Molecular Materials 2000, 12, 101-110.
2592
Singh A, Saxena E and Bhutani KK. Adrenocorticosterone alterations in male, albino mice treated with Trichopus zeylanicus, Withania somnifera and Panax ginseng preparations Phytotherapy Research 2000, 14, 122-125.
2593
Singh S and Bakshi M. Guidance on conduct of stress tests to determine inherent stability of drugs Pharmaceutical Technology 2000, 24, 14-1.
2594
Singh S and Singh PP. Morphine modulation of plasmodial-antigens-induced colony-stimulating factors production by macrophages Life Sciences 2000, 67, 1035-1045.
2595
Singh S, Manikandan R and Singh S. Stability testing for gelatin based formulations: rapidy evaluating the possibility of a reduction in dissolution rates Pharmaceutical Technology 2000, 24, 58-72.
2596
Singh S, Mariappan TT, Sharda N and Singh B. Degradation of rifampicin, isoniazid, and pyrazinamide from prepared mixtures and marketed single and combination products in acid conditions Pharmacy and Pharmacology Communications 2000, 6, 491-494.
2597
Singh S, Mariappan TT, Sharda N, Kumar S and Chakraborti AK. The reason for an increase in decomposition of rifampicin in the presence of isoniazid under acid conditions Pharmacy and Pharmacology Communications 2000, 6, 405-410.
2598
Verma RK, Mishra B and Garg S. Osmotically controlled oral drug delivery Drug Development and Industrial Pharmacy 2000, 26, 695-708.
2599
Vermani K and Garg S. The scope and potential of vaginal drug delivery Pharmaceutical Science & Technology Today 2000, 3, 359-364.
2600
Chakraborti AK and Kaur G. One-pot synthesis of nitriles from aldehydes under microwave irradiation: influence of the medium and mode of microwave irradiation on product formation Tetrahedron 1999, 55, 13265-13268.
2601
Chakraborti AK, Basak (nee Nandi) A and Grover V. Chemoselective protection of carboxylic acid as methyl ester: A practical alternative to diazomethane protocol Journal of Organic Chemistry 1999, 64, 8014-8017.
2602
Chakraborti AK, Nayak MK and Sharma L. Selective Deprotection of Aryl Acetates, Benzoates, Pivalates, and Tosylates under Nonhydrolytic and Virtually Neutral Conditions Journal of Organic Chemistry 1999, 64, 8027-8030.
2603
Gandhi R, Kaul CL and Panchagnula R. Extrusion and spheronization in the development of oral controlled-release dosage forms Pharmaceutical Science & Technology Today 1999, 2, 160-170.
2604
Jaiswal J, Ramarao P and Panchagnula R. Transdermal delivery of naloxone: ex vivo permeation studies International Journal of Pharmaceutics 1999, 179, 129-134.
2605
Kaul CL. Role of sympathetic nervous system in experimental hypertension and diabetes mellitus Clinical and Experimental Hypertension 1999, 21, 95-112.
2606
Panchagnula R, Anand BD, Kaur K, Singh I and Kaul CL. Determination of Paclitaxel in Human Plasma by HPLC Pharmacy and Pharmacology Communications 1999, 5, 587-589.
2607
Panchagnula R, Kaur KJ, Singh I and Kaul CL. The WHO simplified study protocol in practice: investigation of combined formulations supplied by the WHO International Journal of Tuberculosis and Lung Disease 1999, 3, S336-S342..
2608
Panchagnula R, Singh I, Kaur KJ and Kaul CL. Bioequivalence study of rifampicin in fixed-dose combination of rifampicin and isoniazid vs. separate formulations Methods and Findings in Experimental and Clinical Pharmacology 1999, 21, 625-628.
2609
Panchagnula R, Sood A, Sharda N, Kaur K and Kaul CL. Determination of rifampicin and its main metabolite in plasma and urine in presence of pyrazinamide and isoniazid by HPLC method Journal of Pharmaceutical and Biomedical Analysis 1999, 18, 1013-1020.
2610
Rajnikant, Gupta VK, Goswami KN, Magotra DK, Bhutani KK and Gupta DK. Crystal stucture of 4,5-dihydro-6H-tetrazolo [1,5-a]-1-benzazepine, C10H10N4 New Crystal Structures 1999, 214, 377-378.

Information: Duration to be uploaded/incorporated on archival site after the completion of process is 12 months.

2627|58|45